InsidersTradesSigma
Track the Abbisko Cayman Ltd. - B stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Abbisko Cayman Ltd. - B has published 7 insider filings. Market capitalisation: €7.2bn. The latest transaction was disclosed on 9 June 2026 (Purchase). Among the most active insiders: JI JING. All data is openly available.
Analysts rate Abbisko Cayman Ltd. - B Strong Buy (bullish), based on 6 analysts. Average price target: HK$21.69.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
Abbisko Cayman Ltd. - B is a company focused on the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).